Reimbursement in the rare disease landscape is complex. IMAC specializes in the transformation of evidence into a value story that makes payers want to engage.
IMAC is a specialized market access consulting firm based on my decades of experience as an executive in the pharma industry and as a senior consultant in a large consulting company.
For well over 15 years, our inspired, dedicated, and specialist team has been the framework of our overall value. Our goal is to continue to demonstrate our relentless commitment—exemplifying our integrity, innovative solutions, and exceptional personalized support.
Since 2006, in this ever-evolving environment, we have collaborated with our clients bringing highly specialized technologies to targeted patient populations. IMAC has gained a vast knowledge of how to gain market access for your therapies and improve patient outcomes.
Louise Perraut
President and CEO
IMAC consists of highly experienced, senior consultants with decades of successful projects. Along with our extended network of experts, our team is uniquely positioned to provide innovative and strategic methods to ensure the success of your project.
The global reimbursement landscape is rapidly evolving, with more highly specialized therapies and treatments for rare diseases emerging every day. Our team has an unparalleled track record of success in navigating these complexities and securing access for innovative therapies.
Amid rising healthcare costs, strategic economic modeling is essential for successful reimbursement in today’s markets. Our highly experienced HEOR team brings decades of expertise in developing innovative economic models to support effective market access and reimbursement strategies.
Market access for rare diseases presents unique challenges: limited data, a knowledge gap among payers, higher pricing, and a lack of tailored evaluation frameworks. Partnering with our team, with deep expertise in rare disease market access strategies, helps overcome these barriers and ensures effective access for innovative treatments.
Real-world evidence (RWE) is increasingly crucial for informed decision-making by regulators, payers, and providers, shaping the evolving landscape of market access. Discover how our expertise in RWE generation can support your access strategy.
projects
countries
submission success
years of experience
We are a team of experts with decades of industry and consultancy experience that we put to use for you!
The size or our organization allows us to be adaptable, agile, and offer a customized service based on your organizational and project specific needs.
We are known for our innovative strategy and finding solutions for even the most challenging problems.
Your goals are our goals. We look to develop a long-lasting partnership. Our business runs on repeat customers who are highly satisfied with our support!
Our goal is to assist you to bring your therapy to patients in need. We believe in the incredible impact of your success in the lives of patients, their families, and the medical profession.
Fill out the form below, and our dedicated team will be in touch to discuss tailored solutions for you.